AzTrials
AzTrials

ColonoscopyNCT06878378

Risk Factors for Inadequate Bowel Preparation Before Colonoscopy

An observational study of Colonoscopy and Colonoscopy: Bowel Preparation, run by Changhai Hospital at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The primary objectives of this study are twofold: Firstly, to investigate the current status of bowel preparation protocols and their quality across hospitals at various levels in China, particularly following the release of the updated 2023 bowel preparation guidelines. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Colonoscopy, Colonoscopy: Bowel Preparation
What is being tested?
Investigation of Factors Influencing Bowel Preparation Quality
How many people
10,000 participants
Where
1 siteChina
Study dates
21 Feb 2025to 1 Feb 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The target population includes outpatients and inpatients scheduled for colonoscopy or polypectomy in the gastroenterology departments of participating centers between February 2025 and February 2026.

Who may be able to join

  • Patients aged >18 years, regardless of gender, scheduled for colonoscopy
  • Written informed consent has been obtained

Who cannot join

  • History of acute myocardial infarction (within 6 months), severe cardiac/hepatic/renal insufficiency, or psychiatric disorders
  • Current use of anticoagulants (e.g., aspirin, warfarin) or presence of coagulation disorders
  • Pregnancy or lactation;
  • History of inflammatory bowel disease or acute intestinal infection within the past 2 weeks;
  • History of colorectal cancer, familial adenomatous polyposis (FAP), or Peutz-Jeghers syndrome;
  • History of intestinal obstruction, perforation, stricture, or other conditions precluding completion of colonoscopy;
Show all 11Show fewer
  • Non-compliance with bowel preparation protocols (e.g., ingestion of <80% of prescribed polyethylene glycol (PEG) electrolyte solution);
  • Severe hearing impairment, cognitive dysfunction, or inability to cooperate with the study;
  • Prior enrollment in this study with a repeat colonoscopy appointment;
  • Current participation in other clinical trials or participation in any trial within the preceding 60 days;
  • Refusal to provide written informed consent.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

China1 site, 1 recruiting
  • Changhai Hospital

    Shanghai, Shanghai Municipality, 200433

    Zhao-shen Li, 0086-13386273620, zhaoshenli@hotmail.com

    Zi-xuan He, 0086-15901597359, zixuan931004@163.com

    Recruiting

Other trials in China

About this study

Official title: Identification of Risk Factors for Inadequate Bowel Preparation Before Colonoscopy and Construction of a Predictive Model: a Nationwide Multicenter Prospective Study

The primary objectives of this study are twofold:

Firstly, to investigate the current status of bowel preparation protocols and their quality across hospitals at various levels in China, particularly following the release of the updated 2023 bowel preparation guidelines. This aims to standardize and optimize bowel preparation protocols nationwide.

Secondly, to identify and analyze risk factors contributing to suboptimal bowel preparation quality in patients undergoing colonoscopy. The study will examine the correlation between these factors and bowel preparation scores, establish a risk prediction model for preparation failure, and provide a theoretical foundation for developing personalized bowel preparation regimens tailored to individual patient characteristics.

Read the detailed description

The project is divided into three key phases:

  1. Initiation Phase: Develop a Bowel Preparation Assessment Questionnaire (BPAQ) to standardize data collection. Establish collaborative centers (multicenter hospitals) nationwide for coordinated implementation.
  2. Implementation Phase: Conduct on-site audits to evaluate bowel preparation practices across participating centers. Deliver protocol-specific training to healthcare providers, emphasizing compliance with the 2023 guidelines. Systematically collect bowel preparation data, including patient demographics, protocol adherence metrics, and clinical outcomes.
  3. Conclusion Phase:

Prioritize data quality assurance through dual-entry validation and logic checks to ensure authenticity, comprehensiveness, and objectivity.

Generate consolidated reports to identify systemic gaps and propose evidence-based optimization strategies.

Being tested
Investigation of Factors Influencing Bowel Preparation Quality
Keywords
bowel preparation, colonoscopy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Investigation of Factors Influencing Bowel Preparation QualityOther

    Observed parameters include BMI, history of abdominal surgery, history of diabetes, history of diarrhea and constipation, stool characteristics, and specific bowel preparation protocols.

Study groups in NCT06878378
Study groupRoleWhat they receive
outpatients and inpatients scheduled for colonoscopy or polypectomyThe target population includes outpatients and inpatients scheduled for colonoscopy or polypectomy in the gastroenterology departments of participating centers between February 2025 and December 2026. Data from these individuals will be collected to assess factors influencing bowel preparation quality.
Receives: Other: Investigation of Factors Influencing Bowel Preparation Quality

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. adequate bowel preparation rate

    Measured: The adequate bowel preparation rate can be assessed immediately upon completion of colonoscopy

Secondary outcomes (1)
  1. adenoma detection rate

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Mar 2025
  2. Study start21 Feb 2025
  3. Primary completion1 Feb 2026 (estimated)
  4. Study completion1 Feb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
10,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06878378
Sponsor's protocol ID
CHEC2025-083
Status last verified
Mar 2025
First submitted
13 Mar 2025
Last updated
18 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Colonoscopy and Colonoscopy: Bowel Preparation, run by Changhai Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 18 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Zhao-shen Li (0086-13386273620, zhaoshenli@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

adequate bowel preparation rate (time frame: The adequate bowel preparation rate can be assessed immediately upon completion of colonoscopy). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in